DrugDashboards

Clindamycin Palmitate Hydrochloride (Pediatric)

Clindamycin Palmitate Hydrochloride · CLINDAMYCIN PALMITATE HYDROCHLORIDE 75 mg/5mL · Powder, For Solution · Oral · Amneal Pharmaceuticals LLC

NDC 65162-0468-19 · 1 BOTTLE in 1 CARTON / 100 mL in 1 BOTTLE · ANDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. The price is down 24% over the past year, to $0.1302 per mL. Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.1302per MLinvoice-surveyed acquisition cost · Aug 19, 2026
  • Medicaid generic ceiling (FUL)$0.1596per MLweighted avg manufacturer price $0.0912 · Aug 1, 2026123% of what pharmacies pay — higher than 71% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.2$0.4$0.6Jul 2014Sep 2026$0.1302
146 price points · per ML · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

WAC per package, as filed
$47.00
Reported to Texas DSHS · 2026 annual filing · Amneal Pharmaceuticals LLC

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$54,507
1,018 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

28Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • 2 active manufacturers+20
  • price down 28% year over year+8

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for clindamycin palmitate hydrochloride (other) in the next 90 days

sole-source market · 1 Class I/II recall(s) in 12 months

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA203513
TE code
Approval date
Mar 13, 2014
Patents / exclusivity
None on file

Shortage history

  • Planned discontinuation Clindamycin Palmitate Hydrochloride, Injection, 75 mg/5 mL (NDC 53746-468-19)Feb 27, 2026

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Clindamycin Palmitate Hydrochloride (Powder, For Solution)

LabelerStrengthFirst seenLast seen
Amneal Pharmaceuticals LLCCLINDAMYCIN PALMITATE HYDROCHLORIDE 75 mg/5mLJul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals of New York LLCCLINDAMYCIN PALMITATE HYDROCHLORIDE 75 mg/5mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Clindamycin Palmitate Hydrochloride (Pediatric) — NDC 65162-0468-19," retrieved September 3, 2026, https://drugdashboards.com/drug/65162046819.

Free to cite with attribution — see how the data is put together.